While the roles of metabolism and HDACs are well documented in cancers, several studies have also uncovered a pivotal role for HDACs in glucose homeostasis [68], suggesting that HDAC inhibitors may be effective at mitigating diabetes and metabolic disorders. This evidence concerns the gene HDAC9 and Other metabolic disease.